ACADL and hepatocellular carcinoma: Pathway analysis revealed that besides fatty acid metabolic process, the DEGs were also significantly enriched in Hippo pathway, implying the involvement of Hippo signaling in ACADL-mediated HCC growth inhibition (Fig. 3a).